Home> Products> specific egfr mutations

{ "products": [ { "_id": "69d8e821f75e521c210f0942", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nilotinib 150mg", "description": "NILOTHERAPY 150 is a prescription medication containing Nilotinib 150 mg, a targeted therapy primarily used in the treatment of certain types of blood cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins responsible for cancer cell growth. This medication is widely prescribed for patients diagnosed with Chronic Myeloid Leukemia (CML), especially those who are resistant or intolerant to other treatments.\n\nNILOTHERAPY 150 is designed to provide effective disease control while improving long-term outcomes and quality of life for patients.\n\nWhat is Nilotinib 150 mg?\n\nNilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, an abnormal protein produced in patients with Chronic Myeloid Leukemia. By inhibiting this protein, NILOTHERAPY 150 helps slow down or stop the uncontrolled growth of cancer cells.\n\nUnlike traditional chemotherapy, Nilotinib is a targeted therapy, meaning it focuses on cancer cells with minimal damage to healthy cells, making it a more precise and often better-tolerated treatment option.\n\nUses of NILOTHERAPY 150\n\nNILOTHERAPY 150 is primarily prescribed for:\n\n1. Chronic Myeloid Leukemia (CML)\nUsed in adults and children diagnosed with Philadelphia chromosome-positive CML.\nEffective in both newly diagnosed patients and those who cannot tolerate other treatments like Imatinib.\n2. Resistant or Intolerant CML Cases\nHelps patients who have not responded adequately to first-line therapies.\nOffers an alternative with improved efficacy in certain resistant mutations.\n3. Long-Term Disease Management\nHelps maintain remission and prevent disease progression to advanced stages such as accelerated or blast phase CML.\nKey Benefits of NILOTHERAPY 150\n1. Targeted Cancer Therapy\n\nNILOTHERAPY 150 directly targets cancer-causing proteins, minimizing damage to healthy cells and reducing many of the harsh side effects associated with chemotherapy.\n\n2. High Effectiveness\n\nClinical studies have shown that Nilotinib can achieve faster and deeper molecular responses compared to older treatments.\n\n3. Improved Survival Rates\n\nPatients using Nilotinib often experience better long-term survival outcomes when taken as prescribed.\n\n4. Oral Administration\n\nUnlike intravenous cancer treatments, NILOTHERAPY 150 is taken orally, making it convenient and easier to incorporate into daily life.\n\n5. Reduced Disease Progression\n\nHelps prevent the progression of CML into more aggressive stages, offering better disease control.\n\n6. Suitable for Resistant Cases\n\nEffective for patients who do not respond well to first-generation TKIs, providing a second chance at disease management.\n\nHow NILOTHERAPY 150 Works\n\nNilotinib works by blocking the activity of the BCR-ABL tyrosine kinase enzyme. This enzyme sends signals that tell cancer cells to grow and divide uncontrollably. By inhibiting this signal, NILOTHERAPY 150:\n\nStops cancer cell multiplication\nInduces cancer cell death\nHelps restore normal blood cell production\nDosage and Administration\nTypically taken twice daily on an empty stomach (at least 2 hours after a meal and 1 hour before the next meal).\nSwallow capsules whole with water.\nAlways follow your doctor’s prescribed dosage and schedule.\n\n⚠️ Do not adjust the dose without medical advice.\n\nPossible Side Effects of NILOTHERAPY 150\n\nLike all medications, NILOTHERAPY 150 may cause side effects. While not everyone experiences them, it’s important to be aware:\n\nCommon Side Effects\nHeadache\nNausea\nFatigue\nSkin rash\nConstipation or diarrhea\nSerious Side Effects\nHeart rhythm problems (QT prolongation)\nLiver function abnormalities\nPancreatitis\nLow blood cell counts\nIncreased blood sugar levels\nWhen to Seek Medical Help\n\nContact your doctor immediately if you experience:\n\nChest pain or irregular heartbeat\nSevere abdominal pain\nUnusual bleeding or bruising\nYellowing of skin or eyes\nPrecautions and Warnings\nInform your doctor if you have a history of heart disease, liver problems, or electrolyte imbalances.\nAvoid grapefruit and grapefruit juice as they may interfere with the drug’s effectiveness.\nRegular blood tests and monitoring are essential during treatment.\nNot recommended during pregnancy or breastfeeding unless advised by a healthcare professional.\nDrug Interactions\n\nNILOTHERAPY 150 may interact with other medications, including:\n\nAntifungal drugs\nAntibiotics\nHeart medications\nCertain antidepressants\n\nAlways inform your healthcare provider about all medicines and supplements you are taking.\n\nStorage Instructions\nStore in a cool, dry place below 25°C\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nNILOTHERAPY 150 (Nilotinib 150 mg) is a highly effective, targeted treatment for Chronic Myeloid Leukemia, offering patients a modern alternative to traditional chemotherapy. Its ability to specifically inhibit cancer-causing proteins makes it a powerful tool in controlling disease progression and improving long-term survival.", "price": 3270.0, "discountamount": 981.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2375, "imageuri": "https://productimages.withfloats.com/actual/69d8e8255352fce06529f51e.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d8e8255352fce06529f51e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-10T12:08:01.629Z", "updatedon": "2026-04-14T12:51:27.608Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nilotinib-150mg/2375", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NILOTHERAPY 150", "category": "Oncology", "tags": [ "nilotinib 150mg", "nilotinib 150mg capsule", "nilotinib side effects", "nilotinib 150 mg price", "nilotinib 150 mg", "nilotinib 150 mg price", "nilotinib 150mg availability in india", "buy nilotinib 150mg online india prescription", "nilotinib 150mg side effects long term use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-04-15T10:27:12.329Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662e95edb100e1fdc2dd5d6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400 \nImatinib IP 400mg\n Cancer treatment has advanced significantly over the years, and targeted therapies have transformed outcomes for many patients. One such breakthrough medicine is Imatinib IP 400mg, marketed as IMATIFLOW 400. This medication is widely used in the treatment of certain types of cancers and blood disorders by targeting the underlying disease process at the molecular level.\n\nIMATIFLOW 400 is a trusted formulation of Imatinib that offers effective disease control while improving quality of life when used as prescribed under medical supervision.\n\nWhat Is Imatinib IP 400mg?\n\nImatinib IP 400mg belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs). Unlike traditional chemotherapy that attacks rapidly dividing cells, Imatinib works by specifically blocking abnormal proteins responsible for cancer cell growth.\n\nIMATIFLOW 400 is primarily prescribed for:\n\nChronic Myeloid Leukemia (CML)\n\nGastrointestinal Stromal Tumors (GIST)\n\nCertain rare blood and bone marrow disorders\n\nBy acting at the root cause of disease, Imatinib IP 400mg has become a cornerstone of modern targeted cancer therapy.\n\nHow IMATIFLOW 400 Works\n\nIMATIFLOW 400 works by inhibiting abnormal tyrosine kinase enzymes that signal cancer cells to grow and multiply uncontrollably.\n\nMechanism of Action:\n\nCancer cells produce abnormal proteins due to genetic mutations\n\nThese proteins send continuous growth signals\n\nImatinib blocks these signals\n\nCancer cell growth slows down or stops\n\nDiseased cells gradually die while healthy cells are largely spared\n\nThis targeted approach makes IMATIFLOW 400 more precise and often better tolerated compared to conventional chemotherapy.\n\nUses of Imatinib IP 400mg (IMATIFLOW 400)\n1. Chronic Myeloid Leukemia (CML)\n\nIMATIFLOW 400 is widely used as a first-line treatment for patients with Philadelphia chromosome-positive CML. It helps control disease progression and allows many patients to live longer, more stable lives.\n\n2. Gastrointestinal Stromal Tumors (GIST)\n\nIn patients with inoperable or metastatic GIST, Imatinib IP 400mg helps shrink tumors and prevent further growth.\n\n3. Acute Lymphoblastic Leukemia (ALL)\n\nIn certain cases of Philadelphia chromosome-positive ALL, IMATIFLOW 400 is used as part of combination therapy.\n\n4. Other Rare Conditions\n\nIMATIFLOW 400 may also be prescribed for:\n\nMyelodysplastic syndromes\n\nHypereosinophilic syndrome\n\nCertain dermatological and hematological disorders\n\nKey Benefits of IMATIFLOW 400\nTargeted Cancer Therapy\n\nIMATIFLOW 400 targets cancer cells at a molecular level, reducing unnecessary damage to healthy cells.\n\nImproved Survival Rates\n\nLong-term studies show that Imatinib significantly improves survival and disease control in CML and GIST patients.\n\nOral Administration\n\nUnlike injectable chemotherapy, IMATIFLOW 400 is taken orally, making treatment more convenient.\n\nBetter Quality of Life\n\nPatients often experience fewer severe side effects compared to traditional cancer therapies.\n\nLong-Term Disease Management\n\nMany patients remain on Imatinib therapy for years with stable disease control.\n\nAdvantages of IMATIFLOW 400 Over Conventional Chemotherapy\n\nSpecific action on cancer-causing proteins\n\nLower toxicity profile\n\nReduced hospital visits\n\nImproved patient compliance\n\nSuitable for long-term treatment\n\nThese advantages make IMATIFLOW 400 a preferred choice in targeted oncology care.\n\nDosage and Administration\n\nThe usual dose of Imatinib IP 400mg is one tablet once daily\n\nShould be taken with food and a full glass of water\n\nDosage may vary depending on disease type, stage, and patient response\n\nAlways follow the oncologist’s instructions strictly\n\nDo not stop or adjust the dose without medical advice, as this may affect treatment outcomes.\n\nSide Effects of Imatinib IP 400mg\n\nLike all medicines, IMATIFLOW 400 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nNausea and vomiting\n\nDiarrhea\n\nMuscle cramps\n\nFatigue\n\nHeadache\n\nSwelling around eyes or ankles\n\nMild skin rash\n\nThese side effects are usually manageable and improve as the body adjusts to the medicine.\n\nSerious Side Effects\n\nAlthough uncommon, some patients may experience serious side effects, including:\n\nSevere fluid retention\n\nLiver function abnormalities\n\nLow blood cell counts\n\nSevere skin reactions\n\nHeart-related complications (rare)\n\nImmediate medical attention is required if severe symptoms occur.\n\nPrecautions and Warnings\n\nRegular blood tests are required during treatment\n\nLiver function monitoring is important\n\nInform the doctor about all other medicines being taken\n\nUse with caution in patients with heart or liver disease\n\nNot recommended during pregnancy unless clearly advised\n\nBreastfeeding should be avoided during treatment\n\nDrug Interactions\n\nIMATIFLOW 400 may interact with:\n\nCertain antibiotics\n\nAntifungal medicines\n\nBlood thinners\n\nHerbal supplements like St. John’s Wort\n\nAlways inform your doctor about any medication or supplement you are using.\n\nWho Should Take IMATIFLOW 400?\n\nPatients diagnosed with CML\n\nPatients with GIST\n\nIndividuals prescribed targeted therapy by an oncologist\n\nPatients requiring long-term cancer management\n\nStorage Instructions\n\nStore at room temperature\n\nKeep away from moisture and heat\n\nKeep out of reach of children\n\nDo not use after the expiry date\n\nFrequently Asked Questions\nIs IMATIFLOW 400 chemotherapy?\n\nNo, it is a targeted therapy, not traditional chemotherapy.\n\nHow long should Imatinib IP 400mg be taken?\n\nTreatment duration depends on disease response and medical advice. Some patients take it long-term.\n\nCan IMATIFLOW 400 cure cancer?\n\nIt helps control and manage cancer effectively, and in many cases keeps the disease in remission.\n\nIs IMATIFLOW 400 safe for long-term use?\n\nYes, when monitored regularly under medical supervision.\n\nConclusion\n\nIMATIFLOW 400 (Imatinib IP 400mg) represents a major advancement in cancer treatment through its targeted mechanism of action. By directly blocking the proteins responsible for cancer growth, it offers effective disease control with improved tolerability. When taken correctly and under medical guidance, IMATIFLOW 400 can significantly enhance survival, stability, and quality of life for patients battling chronic and complex cancers.", "price": 1827.0, "discountamount": 549.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "CML", "Call", "GIST", "Email", "400mg", "types", "cancers", "therapy", "WhatsApp", "IMATIFLOW", "medication", "information", "Imatinib IP", "progression", "sterispharma", "sterisonline", "proliferation", "patient outcomes", "cancer cell growth", "healthcare professional", "chronic myeloid leukemia", "specific tyrosine kinases", "gastrointestinal stromal tumors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1532, "imageuri": "https://productimages.withfloats.com/actual/667d2405422dd0be2672303b.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2405422dd0be2672303b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T11:05:02.332Z", "updatedon": "2026-03-16T11:55:37.907Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-ip-400mg/1532", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400 ", "category": "Oncology", "tags": [ "imatinib 400 mg uses", "side effects of imatinib 400 mg", "imatinib 400 mg uses in hindi", "imatinib 400 mg price in india", "imatinib ip 400mg tablet", "imatinib ip 400 mg uses", "imatinib 400mg tablet ip", "imatinib ip 400mg price in india", "imatinib 400mg dosage guide", "imatinib ip 400mg side effects", "imatinib 400mg tablet composition", "imatinib ip 400mg for leukemia", "imatinib 400mg for cml treatment", "imatinib ip 400mg medicine", "imatinib 400mg tablet how to use", "imatinib ip 400mg benefits", "imatinib 400mg oral chemotherapy tablet", "imatinib ip 400mg indications", "imatinib 400mg tablet working mechanism", "buy imatinib ip 400mg tablet", "imatinib ip 400mg manufacturer india", "imatinib 400mg tablet supplier", "imatinib ip 400mg pharmaceutical company", "what is imatinib ip 400mg", "imatinib 400mg tablet for cancer", "imatinib ip 400mg mechanism of action", "imatinib 400mg tablet side effects in patients", "imatinib ip 400mg treatment duration" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e74687f0960e14a2d95a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gefitinib 250mg", "description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n", "price": 2760.0, "discountamount": 828.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "Call", "Uses", "Rash", "Note", "NSCLC", "Email", "nausea", "Dosage", "spread", "WhatsApp", "diarrhea", "Gefitinib", "treatment", "One tablet", "GEFISTERIS", "information", "sterispharma", "consultation", "sterisonline", "Side Effects", "cancer cells", "targeted therapy", "Regular monitoring", "healthcare provider", "small cell lung cancer", "healthcare professional", "specific EGFR mutations", "epidermal growth factor receptor", "potential liver function alterations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1530, "imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:56:06.808Z", "updatedon": "2026-04-15T10:04:00.767Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GEFISTERIS 250", "category": "Oncology", "tags": [ "gefitinib 250 mg uses", "gefitinib 250 mg online purchase", "gefitinib 250 mg tablets price in india", "non-small cell lung cancer (NSCLC).", "triggered by chemotherapy.", "cancer biology.", "Superior Efficacy in EGFR-Mutant NSCLC", "gefitinib 250mg", "gefitinib 250mg tablet", "gefitinib 250mg tab", "gefitinib 250 mg tablet uses in lung cancer", "gefitinib tablets 250 mg dosage and benefits", "gefitinib 250 mg price in india", "gefitinib 250 mg EGFR inhibitor for NSCLC treatment india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6abe4471401ae1a1106d67d9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Bisoprolol 1.25mg", "description": "Bisoprolol 1.25mg is the smallest tablet strength of bisoprolol, a heart-selective beta-1 blocker. Doctors usually prescribe it to start treatment or to build up the dose gradually in people with high blood pressure, chronic stable heart failure, or fast heart rhythms. It suits older adults, people with mild heart failure, and anyone who reacts strongly to beta-blockers. The medicine slows the heartbeat and eases the force of each contraction, so the heart works less hard. BISOGARD 1.25 from Steris Healthcare Pvt. Ltd. comes in a strip pack of 15 tablets. It is a Schedule H medicine, so it must only be started, changed, or stopped on a doctor's advice.\n\nProduct Snapshot\n\nBrand: BISOGARD 1.25\nManufacturer/Marketer: Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company in India\nActive ingredient: Bisoprolol Fumarate 1.25mg\nForm: Tablet\nPack size: 15 tablets\nDrug class: Cardioselective beta-1 blocker\nLegal status: Schedule H (valid prescription required)\nAvailability: Through Steris Healthcare's authorized pharmacies and its B2B PCD franchise network across India\nWhat Is Bisoprolol 1.25mg?\n\nIf your doctor has just prescribed bisoprolol 1.25mg, you have been given the lowest dose on purpose. Bisoprolol is a cardioselective beta-1 blocker, meaning it acts mostly on receptors in the heart and has much less effect on the lungs and blood vessels. This is a major reason it is preferred over older, non-selective beta-blockers, especially for people who also have a mild breathing problem.\n\nThe 1.25mg tablet is not a “light” medicine for mild illness. It is a carefully chosen entry point. In heart failure, a weakened heart can struggle if its rate or pressure drops too quickly, so cardiologists follow a “start low, go slow” approach. Treatment begins at 1.25mg, the response is watched for one to two weeks, and the dose is raised step by step (commonly 2.5mg, 3.75mg, 5mg, 7.5mg, and up to 10mg) as the heart adapts. That is why BISOGARD 1.25 is often the first tablet a newly diagnosed heart failure patient takes.\n\nWhat Is Bisoprolol 1.25mg Used For?\n\nDoctors commonly prescribe this strength for:\n\nChronic heart failure (HFrEF): as the first step of dose titration in patients with a reduced ejection fraction, alongside ACE inhibitors/ARBs and diuretics\nHigh blood pressure: especially in older adults, people with low body weight, and those who are sensitive to blood-pressure-lowering drugs\nStable angina: to reduce the heart's oxygen demand and relieve chest discomfort\nAfter a heart attack: in selected patients, under a cardiologist's care\nHeart rate control in some arrhythmias: sometimes used off-label at a low dose to gently bring down a fast heart rate\n\nAt 1.25mg, bisoprolol is seldom meant as the long-term sole treatment for high blood pressure in an otherwise healthy adult. It is usually the first rung of a titration ladder, or a steady maintenance dose for patients who are unusually beta-blocker sensitive (older age, low body weight, or borderline low pressure or pulse).\n\nHow Does Bisoprolol Work?\n\nBisoprolol selectively blocks beta-1 adrenergic receptors, which are packed mainly into heart muscle. This leads to several effects:\n\nSlower heart rate: the heart has more time to fill and rest between beats\nGentler contractions: the heart muscle needs less oxygen and energy\nLess renin from the kidneys: this helps blood pressure fall gradually over time\nLower overall cardiac workload: a real advantage for a heart that already struggles to pump well, as in heart failure\nKey Benefits of BISOGARD 1.25\nA gentle starting dose, well suited to careful titration in frail or elderly patients\nHeart-focused action, with less effect on the lungs and peripheral blood vessels than non-selective beta-blockers\nOnce-daily dosing, which makes it easier to stay on treatment\nA guideline-recommended beta-blocker for HFrEF with well-established outcomes data [Reviewer note: insert specific outcome statistics/trial citation pending medical sign-off]\nMade by Steris Healthcare Pvt. Ltd. under WHO-GMP and ISO-certified standards\nDosage Guidance\nUsual starting dose (heart failure): 1.25mg once a day, preferably in the morning\nDose increases: typically every 1–2 weeks (2.5mg, 3.75mg, 5mg, 7.5mg, up to a maximum of 10mg daily), depending on how well you tolerate it and on your pulse and blood pressure\nHigh blood pressure (sensitive patients): 1.25mg to 5mg once daily, as set by your doctor\nHow to take it: at the same time every day, with or without food, swallowed whole with water\nIf you miss a dose: take it when you remember, unless the next dose is almost due. Never take a double dose.\nNever stop suddenly: abrupt withdrawal can cause a rebound rise in heart rate, blood pressure, or chest pain. The dose must be reduced gradually under medical supervision.\nIs It Better to Take Bisoprolol in the Morning or at Night?\n\nMost doctors advise a morning dose. Bisoprolol lowers pulse and blood pressure, and taking it early matches its action to your daytime activity. A night-time dose could add to the body's natural overnight dip in blood pressure and raise the chance of dizziness when getting up in the dark. Some people who feel tired during the day are told by their doctor to switch to the evening. Do not change your dosing time without your doctor's approval.\n\nSide Effects of Bisoprolol 1.25mg\n\nCommon side effects\n\nTiredness or fatigue\nDizziness or light-headedness, especially on standing quickly\nCold hands or feet\nSlow pulse (bradycardia)\nHeadache\nMild stomach upset (nausea, loose stools)\nDisturbed sleep\n\nSerious side effects (get medical help promptly)\n\nVery slow heartbeat or fainting\nIncreasing breathlessness or swollen legs/ankles, which may mean heart failure is worsening\nAllergic reaction: rash, swelling of the face or throat, trouble breathing\nCold, numb, or bluish fingers and toes\nWheezing or new breathing difficulty, particularly in people with asthma or COPD\nMood changes, low mood, or confusion\nWhat Are the Bad Side Effects of Bisoprolol?\n\nThe effects that need urgent attention are a dangerously slow pulse, fainting, signs of worsening heart failure (swelling, breathlessness), severe allergic reactions, and airway tightening in people with lung disease. These are uncommon at the 1.25mg dose, but anyone who notices them should seek medical help right away. [Reviewer note: specific incidence rates pending clinical/medical sign-off]\n\nSubstitutes & Comparable Beta-Blockers\nMolecule\tSelectivity\tTypical Use Case\nBisoprolol\tHighly cardioselective\tHeart failure titration, hypertension\nMetoprolol Succinate ER\tCardioselective\tHypertension, angina, heart failure\nAtenolol\tCardioselective (older agent)\tHypertension\nCarvedilol\tNon-selective with alpha-blocking action\tHeart failure (adds vasodilation)\nPropranolol\tNon-selective\tMigraine prevention, anxiety-related fast heartbeat, essential tremor\nPrecautions & Who Should Avoid Bisoprolol\nNot suitable for people with severe bradycardia, certain forms of heart block (unless a pacemaker is fitted), unstable or acutely decompensated heart failure, or severe uncontrolled asthma\nUse carefully in diabetes, because beta-blockers can hide the warning signs of low blood sugar\nTake care in peripheral vascular disease, as cold extremities or leg pain on walking may worsen\nNever stop it abruptly; always taper under a doctor's guidance\nTell your doctor about every medicine you use, especially other blood-pressure drugs, calcium channel blockers, and certain antiarrhythmics\nIn pregnancy and breastfeeding, use only if your doctor advises it after weighing benefits and risks\nIs Bisoprolol Safe for Kidneys?\n\nThe body clears bisoprolol through both the liver and the kidneys in roughly equal measure. It is generally considered safe for people with normal or mildly reduced kidney function. When kidney impairment is significant, drug levels in the blood can rise, so your doctor may lower the dose or monitor you more closely. Always tell your prescriber about any kidney disease before starting.\n\nIs Bisoprolol a High-Risk Medication?\n\nBisoprolol is not a narrow therapeutic index drug like tacrolimus or warfarin, where small dose differences matter greatly. Even so, it needs supervised use because it directly affects heart rate and blood pressure. The main dangers are stopping it suddenly, which can set off rebound cardiac events, and using it with certain existing rhythm disorders. Taken as prescribed and checked regularly, it has a long and reassuring safety record.\n\nDoes 1.25mg Bisoprolol Lower Blood Pressure?\n\nYes. Even the smallest dose measurably reduces heart rate and blood pressure by lightening the heart's workload and reducing renin-driven narrowing of blood vessels. At this strength the effect on blood pressure is fairly mild, which is exactly why it is a safe place to begin, especially for older adults or people starting heart failure treatment. The dose is then raised gradually to reach full benefit.\n\nFrequently Asked Questions\n\n1. What is 1.25 mg of bisoprolol used for?\nMainly as a low starting dose when building up treatment for chronic heart failure, and for high blood pressure in people who are very sensitive to beta-blockers, such as older adults.\n\n2. What are the bad side effects of bisoprolol?\nThe more serious ones are a very slow pulse, fainting, worsening heart failure signs (swelling, breathlessness), severe allergy, and breathing trouble in people with lung conditions.\n\n3. What are the common side effects of bisoprolol fumarate 1.25 mg tablets?\nTiredness, dizziness, cold hands and feet, mild headache, and a slightly slower pulse.\n\n4. Is it better to take bisoprolol in the morning or at night?\nMorning is usually preferred so its effect fits daytime activity, though your doctor may suggest evenings in some cases.\n\n5. What is the cost of bisoprolol?\nPrice depends on strength, pack size, and brand. Use the “Check Price” option above for current BISOGARD 1.25 pricing from Steris Healthcare.\n\n6. Does 1.25 mg bisoprolol lower blood pressure?\nYes, though only modestly at this dose. The dose is often stepped up over time.\n\n7. Is bisoprolol safe for kidneys?\nGenerally yes for normal or mildly reduced kidney function. People with significant kidney impairment need dose adjustment and monitoring.\n\n8. Is bisoprolol a high-risk medication?\nIt is not a narrow therapeutic index drug, but it must never be stopped suddenly and should be used under medical supervision because of its direct effect on the heart.\n\n9. Can I take bisoprolol 1.25mg for the rest of my life?\nMany people with chronic heart failure or hypertension do take bisoprolol long term, but the dose usually rises as tolerated. Your doctor should review it regularly.\n\n10. What happens if I miss a dose of bisoprolol?\nTake it when you remember, unless the next dose is nearly due. In that case skip the missed one. Never take two together.\n\n11. Can bisoprolol 1.25mg cause weight gain?\nIt is not commonly reported at this dose. Fluid retention linked to heart failure itself should be reported to your doctor.\n\n12. Is bisoprolol safe for diabetic patients?\nIt can be used, with care, because beta-blockers may hide warning signs of low blood sugar such as a racing heartbeat.\n\n13. Can I stop taking bisoprolol suddenly if I feel fine?\nNo. Stopping abruptly can cause a rebound rise in heart rate, blood pressure, or chest pain. Reduce the dose gradually under medical guidance.\n\n14. Does bisoprolol interact with other blood pressure medicines?\nYes. Combining it with other drugs that lower heart rate or pressure (such as calcium channel blockers) can cause a very low pulse or pressure. Tell your doctor about all your medicines.\n\n15. Is BISOGARD 1.25 available without a prescription?\nNo. Bisoprolol is a Schedule H medicine in India and needs a valid prescription.\n\n16. How long does it take for bisoprolol 1.25mg to start working?\nSome effect on heart rate appears within hours, but the full benefit for blood pressure or heart failure symptoms builds over several weeks of regular use.\n\n17. Can pregnant women take bisoprolol?\nOnly if clearly necessary and prescribed by a doctor, as it may affect the baby's heart rate and growth.", "price": 39.0, "discountamount": 12.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2501, "imageuri": "https://productimages.withfloats.com/actual/6abe4474c205678e0b16a23a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6abe4474c205678e0b16a23a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-01T11:30:57.88Z", "updatedon": "2026-10-01T11:30:57.88Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//bisoprolol-1-25mg/2501", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Bisogard 1.25", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a9532d9dc13d720a47ea143", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tolperisone Hydrochloride Sustained Release Tablets 450 mg", "description": "**Tolperisone hydrochloride** is a centrally acting muscle relaxant used to help reduce excessive muscle tone, stiffness, and muscle spasms associated with certain musculoskeletal and neurological conditions. Compared with some other centrally acting muscle relaxants, tolperisone is generally considered to have relatively limited sedative effects, although individual responses can vary.\n\n**TOPERITME 450** is formulated as a sustained-release tablet. This formulation is designed to release the active ingredient gradually, helping maintain its therapeutic effect over the prescribed dosing period.\n\nWhat TOPERITME 450 May Be Used For\n\nA healthcare professional may prescribe **TOPERITME 450** for conditions involving painful muscle tightness or spasms, including:\n\n* Painful muscle spasms\n* Selected musculoskeletal disorders\n* Neck and shoulder muscle stiffness\n* Lower back discomfort associated with muscle spasm\n* Cervical or lumbar spondylosis accompanied by muscle tightness\n* Muscle spasms associated with injury or trauma\n* Increased muscle tone associated with certain neurological conditions, when clinically appropriate\n\nThe decision to use tolperisone should be based on the patient's symptoms, diagnosis, and medical assessment.\n\nWhy TOPERITME 450 May Be Preferred\n\nTOPERITME 450 may offer several practical advantages when prescribed appropriately:\n\n* Sustained-release formulation for gradual drug delivery\n* Helps reduce muscle spasms and excessive muscle tension\n* May support improved movement when muscle stiffness is limiting mobility\n* Can help relieve discomfort associated with tight muscles\n* Convenient oral tablet formulation\n* Intended for use according to an individualized medical treatment plan\n\nPatients should always follow the dosage and duration recommended by their healthcare provider.\n\nMechanism of Action\n\n**Tolperisone hydrochloride** acts primarily through the central nervous system to reduce abnormal or excessive muscle activity. By modulating nerve signals involved in muscle tone and reflex activity, it can help decrease muscle stiffness and spasms.\n\nThe sustained-release formulation of **TOPERITME 450** is designed to release tolperisone progressively rather than all at once. This provides controlled delivery throughout the prescribed dosing interval.\n\n Dosage and Administration\n\nThe appropriate dose of **TOPERITME 450** should be determined by a qualified healthcare professional according to the patient's condition and treatment requirements.\n\nImportant administration instructions include:\n\n* Take the medicine exactly as prescribed.\n* Swallow the tablet whole with water.\n* Do not crush, chew, or split the sustained-release tablet unless specifically instructed by your doctor.\n* Maintain the prescribed dosing schedule.\n* If you forget a dose, seek guidance from your healthcare provider rather than taking an extra dose independently.\n\n Possible Side Effects\n\nSome individuals may experience side effects while taking **TOPERITME 450**. Potential reactions include:\n\n* Nausea\n* Dizziness\n* Headache\n* Weakness\n* Stomach discomfort\n* Allergic reactions\n\nNot everyone experiences side effects, and their severity can differ between individuals.\n\nIf serious allergic symptoms such as facial or throat swelling, breathing difficulty, or a severe unusual reaction occur, seek immediate medical attention.\n\nPrecautions to Discuss With Your Doctor\n\nBefore starting **TOPERITME 450**, inform your healthcare professional if you have:\n\n* Liver disease\n* Kidney disease\n* A previous history of drug allergies\n* Pregnancy or plans to become pregnant\n* Breastfeeding\n* Any other ongoing medical condition\n* Current use of prescription or over-the-counter medicines\n\nProviding a complete medication history can help your healthcare provider assess potential interactions and determine whether tolperisone is appropriate.\n\n Storage Guidelines\n\nFor proper storage of **TOPERITME 450**:\n\n* Keep the medicine in a cool and dry place.\n* Protect it from excessive moisture.\n* Keep the tablets away from direct sunlight.\n* Store according to the temperature instructions printed on the packaging.\n* Keep the medicine out of children's reach.\n* Do not use tablets after their stated expiry date.\n\nWhy Choose TOPERITME 450?\n\n**TOPERITME 450** contains tolperisone hydrochloride in a sustained-release formulation intended to provide controlled drug delivery. It may be selected by healthcare professionals for suitable patients experiencing muscle spasms, increased muscle tone, or stiffness associated with certain musculoskeletal conditions.\n\nTreatment should be individualized, and the medicine should be taken only according to professional medical advice.\n\n Frequently Asked Questions\n\nWhat is TOPERITME 450 prescribed for?\n\nTOPERITME 450 may be prescribed to help manage painful muscle spasms, stiffness, and increased muscle tone associated with selected musculoskeletal or neurological conditions.\n\nHow should I take TOPERITME 450?\n\nTake TOPERITME 450 exactly as prescribed and swallow the sustained-release tablet whole with water. Do not crush or chew it unless your healthcare professional specifically instructs you to do so.\n\nCan I stop TOPERITME 450 when my symptoms improve?\n\nDo not discontinue or modify your treatment without consulting your healthcare provider. The recommended treatment duration depends on your condition and individual response.\n\nIs TOPERITME 450 safe during pregnancy?\n\nUse during pregnancy should only be considered after consultation with a qualified healthcare professional, who can assess the potential benefits and risks for the individual patient.\n\nCan TOPERITME 450 cause drowsiness?\n\nSome individuals may experience dizziness or drowsiness, while others may not. If you experience impaired alertness, avoid driving or operating machinery until you know how the medicine affects you.", "price": 530.0, "discountamount": 159.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2500, "imageuri": "https://productimages.withfloats.com/actual/6a9532dd5c122cfb47f3b8bb.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a9532dd5c122cfb47f3b8bb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:52:57.389Z", "updatedon": "2026-08-31T07:52:57.389Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tolperisone-hydrochloride-sustained-release-tablets-450-mg/2500", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TOPERITIME 450", "category": "ORTHOPEDICS RANGE", "tags": [ "Tolperisone Hydrochloride Sustained Release Tablets 450 mg", "tolperisone hydrochloride uses", "tolperisone hydrochloride", "tolperisone hydrochloride use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a952f8fed078617ad2e762a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Palmitoylethanolamide,Parsley Extract & Multivitamin Tablets", "description": "What Are Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets?\n\nPalmitoylethanolamide, Parsley Extract & Multivitamin Tablets are a combination of nutritional supplements formulated with **palmitoylethanolamide (PEA), parsley extract, vitamins, and minerals**. The precise ingredients and quantities can differ between products, so the product label should always be checked for the exact composition and recommended serving.\n\nEach component has a different nutritional or biological role. **Palmitoylethanolamide (PEA)** is a naturally occurring fatty-acid amide that has been researched for its potential contribution to pain-related and inflammatory processes. Clinical research has shown particular interest in PEA for pain-management outcomes, especially when specific formulations such as micronized or ultramicronized PEA are used.\n\n**Parsley extract**, obtained from *Petroselinum crispum*, contains naturally occurring plant compounds, including flavonoids and phenolic constituents. Research has identified compounds such as apigenin and apiin in parsley and has demonstrated antioxidant activity in experimental settings. However, laboratory antioxidant activity should not be interpreted as proof that parsley extract prevents or treats a particular disease.\n\nThe multivitamin component supplies selected vitamins and minerals that contribute to normal nutritional requirements. Such supplements can be useful when dietary intake does not provide adequate amounts of particular nutrients, but they are intended to complement rather than replace a balanced diet.\n\nHow Do Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets Work?\n\nThe combination works through the individual characteristics of its principal ingredients rather than through a single mechanism.\n\n1. Palmitoylethanolamide\n\nPalmitoylethanolamide (PEA) is an endogenous lipid compound found naturally in the body. It has been investigated for its potential analgesic, anti-inflammatory, and neuroprotective activities.\n\nClinical research has examined PEA in various pain-related and neurological settings. Evidence from randomized controlled trials has been particularly promising for pain-related outcomes. However, different PEA products can contain different formulations, and results from one preparation should not automatically be applied to every PEA supplement.\n\n 2. Parsley Extract\n\nParsley contains several naturally occurring phytochemicals, including flavonoids and phenolic compounds. These substances have demonstrated antioxidant properties in experimental research.\n\nThe presence of parsley extract therefore adds a plant-derived nutritional component to the formulation. However, human evidence remains more limited than laboratory research, so claims about disease prevention or treatment should be avoided unless supported by appropriate clinical evidence.\n\n3. Vitamins and Minerals\n\nThe multivitamin portion is designed to provide selected micronutrients that contribute to normal body functions. Vitamins and minerals participate in numerous physiological processes, including energy metabolism, immune function, nervous-system function, and maintenance of tissues.\n\nThe actual nutritional contribution depends on which vitamins and minerals are included and their quantities per tablet or serving.\n\nPotential Benefits of Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets\n\nThe potential benefits of this combination depend on its exact formulation and the nutritional requirements of the individual.\n\nSupport for Pain-Management Strategies\n\nPEA is the component in this combination with the most relevant clinical research. Studies have evaluated PEA as a complementary nutritional approach in different pain conditions, with evidence showing particular interest in pain-related outcomes.\n\nHowever, the presence of PEA does not mean that every PEA-containing supplement is clinically proven to treat chronic pain, neuropathy, or other medical disorders.\n\nNutritional Support\n\nThe vitamin and mineral component can help increase nutrient intake when normal dietary consumption is inadequate.\n\nPeople with restricted diets, reduced food intake, or specific nutritional gaps may sometimes benefit from supplementation. However, supplements are not intended to replace a varied and nutritionally balanced diet.\n\nAntioxidant Nutritional Support\n\nParsley provides naturally occurring flavonoids and phenolic compounds that demonstrate antioxidant activity in experimental research.\n\nThese properties make parsley an interesting botanical ingredient in nutritional formulations, although laboratory findings do not necessarily establish a specific clinical benefit in humans.\n\nConvenient Combination Formula\n\nA combination tablet can offer convenience by bringing PEA, parsley extract, vitamins, and minerals together in one formulation.\n\nConsumers should focus on the actual quantities provided per tablet rather than simply the number of ingredients listed on the packaging.\n\nPalmitoylethanolamide, Parsley Extract & Multivitamin Tablets: Uses\n\nDepending on the specific product formulation and labeling, these tablets may be used as a nutritional supplement to\n\n* Support daily nutritional intake\n* Provide selected vitamins and minerals\n* Supply palmitoylethanolamide as part of a complementary wellness or pain-management approach\n* Provide naturally occurring compounds from parsley extract\n* Complement overall nutritional and antioxidant intake\n\nThese supplements should not be promoted as guaranteed treatments or cures for neuropathy, arthritis, inflammation, nerve injury, or other medical diseases.\n\n How to Select the Right Product\n\n 1. Check the PEA Quantity\n\nReview the label to determine the actual amount of **palmitoylethanolamide per tablet or daily serving**.\n\n 2. Consider the PEA Formulation\n\nDifferent clinical studies have evaluated different PEA preparations. Micronized, ultramicronized, and water-dispersible forms have received particular attention in clinical research.\n\n3. Review the Vitamin and Mineral Profile\n\nExamine the complete nutritional panel rather than assuming all multivitamin formulations contain the same nutrients and quantities.\n\n4. Avoid Nutrient Duplication\n\nIf you already use a multivitamin or individual supplements containing nutrients such as vitamin A, iron, zinc, or other minerals, compare the total daily intake to avoid unnecessary excess.\n\n 5. Check Product Information\n\nLook for transparent labeling, manufacturer details, batch information, expiry information, and appropriate quality-control details.\n\n 6. Choose According to Individual Requirements\n\nA product containing more ingredients or higher quantities is not necessarily more beneficial. Selection should be based on individual nutritional requirements and professional guidance when necessary.\n\nPossible Side Effects and Safety\n\nDietary supplements are generally well tolerated when appropriately formulated and used according to directions, but adverse effects and interactions can occur.\n\nPossible problems may include:\n\n* Nausea\n* Stomach discomfort\n* Changes in bowel habits\n* Headache\n* Sensitivity or allergic reactions to individual ingredients\n* Excessive intake of particular vitamins or minerals\n\nThe exact safety profile depends on the complete ingredient list and quantities in the individual product.\n\nPeople who take prescription medicines, have significant medical conditions, are pregnant or breastfeeding, or are preparing for surgery should discuss supplementation with a qualified healthcare professional.\n\nWho Should Use Extra Caution?\n\nAdditional care may be appropriate for individuals who:\n\n* Take several nutritional supplements\n* Regularly use prescription medicines\n* Have an existing medical condition\n* Are pregnant or breastfeeding\n* Have an allergy or sensitivity to an ingredient\n* Are preparing for surgery\n* Are considering supplementation for persistent or unexplained pain\n\nMultivitamins should also not be used as a substitute for a consistently varied diet.\n\nFrequently Asked Questions\n\n1. What are Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets used for?\n\nThey are combination nutritional supplements containing PEA, parsley extract, vitamins, and minerals. Depending on the formulation, they may provide nutritional support and PEA as a complementary component of a wellness or pain-management approach.\n\n2. What are the main benefits of these tablets?\n\nPotential benefits depend on the formulation. PEA has been clinically studied mainly for pain-related outcomes; parsley provides naturally occurring plant compounds; and vitamins and minerals help support nutritional intake when dietary consumption is insufficient.\n\n3. Can Palmitoylethanolamide help with nerve pain?\n\nPEA has been investigated in several pain-related and neurological conditions, with clinical research showing promising findings for some pain outcomes. However, it should not automatically be considered a proven treatment for every type of nerve pain or neuropathy.\n\n4. Are Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets safe?\n\nSafety depends on the ingredients, quantities, individual health status, and medicines being used. Most appropriately used basic nutritional supplements are tolerated by many people, but excessive nutrient intake and interactions can occur.\n\n5. What side effects can these tablets cause?\n\nPotential effects can include stomach discomfort, nausea, bowel changes, headache, or sensitivity to an ingredient. The exact side effects depend on the complete formulation.\n\n6. Can these tablets be taken with another multivitamin?\n\nCombining multivitamins should be approached carefully because overlapping ingredients can result in excessive intake of certain vitamins or minerals. Compare both labels before combining supplements.\n\n7. How should I choose palmitoylethanolamide tablets?\n\nCheck the PEA quantity, formulation, parsley extract amount, complete vitamin and mineral profile, serving instructions, manufacturer information, and product quality details.\n\n8. Can these tablets replace prescribed pain medicines?\n\nNo. A nutritional supplement should not automatically replace prescribed medication or professional medical care. Persistent, severe, worsening, or unexplained pain should be evaluated appropriately.\n\n9. Do multivitamins provide long-term health benefits?\n\nMultivitamins can increase nutrient intake when dietary intake is inadequate, but this does not mean they universally prevent chronic diseases or extend lifespan in healthy individuals.\n\n10. Can I take these tablets every day?\n\nFollow the dosage or serving instructions provided for the specific product. Taking more than the recommended amount does not necessarily provide greater benefits and may increase the risk of excessive nutrient intake.\n\nConclusion\n\nPalmitoylethanolamide, Parsley Extract & Multivitamin Tablets** combine **PEA, parsley extract, vitamins, and minerals** into a single nutritional formulation. PEA is the component with the most relevant clinical research, particularly in relation to pain-related outcomes, while parsley contributes naturally occurring botanical compounds and the multivitamin component supports dietary micronutrient intake.\n\nThe benefits and appropriate use of the combination depend on the exact formulation, ingredient quantities, and individual nutritional requirements. Therefore, consumers should review the complete product label and use the supplement according to its recommended directions.", "price": 579.0, "discountamount": 170.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2499, "imageuri": "https://productimages.withfloats.com/actual/6a952f923833cb5247c5da2d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952f923833cb5247c5da2d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:38:55.369Z", "updatedon": "2026-08-31T07:38:55.369Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//palmitoylethanolamide-parsley-extract-multivitamin-tablets/2499", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PALMI URIDIN 600", "category": "NEUROLOGY RANGE", "tags": [ "Palmitoylethanolamide,Parsley Extract & Multivitamin Tablets", "palmitoylethanolamide", "multivitamin tablets", "best multivitamin tablets", "multivitamin tablets uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }